🎉 M&A multiples are live!
Check it out!

Botanee Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for Botanee Group and similar public comparables like SynBiotic, Lavipharm, and EZZ Life Science.

Botanee Group Overview

About Botanee Group

Yunnan Botanee Bio-Technology Group Co Ltd manufactures and sells skin care and cosmetics. The company develops and sells skin care products such as creams, lotions, masks, essences, and makeup items like BB creams, isolation creams, and removers. It also produces skin care-related medical devices, including hyaluronic acid repair films and dressings, used for protecting sensitive skin and post-procedure care.


Founded

2010

HQ

China
Employees

4.0K+

Website

botanee.com.cn

Sectors

Health & Beauty

Financials

LTM Revenue $788M

LTM EBITDA $120M

EV

$2.3B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Botanee Group Financials

As of September 2025, Botanee Group reported last 12-month revenue of $788M and EBITDA of $120M.

In the same period, Botanee Group generated $588M in LTM gross profit and $78.3M in net income.

See Botanee Group valuation multiples based on analyst estimates

Botanee Group P&L

In the most recent fiscal year, Botanee Group reported revenue of $805M and EBITDA of $114M.

Botanee Group expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Botanee Group valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $788M XXX $805M XXX XXX XXX
Gross Profit $588M XXX $593M XXX XXX XXX
Gross Margin 75% XXX 74% XXX XXX XXX
EBITDA $120M XXX $114M XXX XXX XXX
EBITDA Margin 15% XXX 14% XXX XXX XXX
EBIT $89.1M XXX $80.8M XXX XXX XXX
EBIT Margin 11% XXX 10% XXX XXX XXX
Net Profit $78.3M XXX $70.6M XXX XXX XXX
Net Margin 10% XXX 9% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Botanee Group Stock Performance

Botanee Group has current market cap of CNY 19.4B (or $2.7B), and EV of CNY 16.4B (or $2.3B).

Market Cap Evolution

Botanee Group Stock Data

As of October 17, 2025, Botanee Group's stock price is CNY 46 (or $6).

See Botanee Group trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.3B $2.7B XXX XXX XXX XXX $0.18

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Botanee Group Valuation Multiples

Botanee Group's trades at 2.9x EV/Revenue multiple, and 20.1x EV/EBITDA.

See valuation multiples for Botanee Group and 15K+ public comps

Botanee Group Financial Valuation Multiples

As of October 17, 2025, Botanee Group has market cap of $2.7B and EV of $2.3B.

Equity research analysts estimate Botanee Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Botanee Group has a P/E ratio of 34.8x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $2.7B XXX $2.7B XXX XXX XXX
EV (current) $2.3B XXX $2.3B XXX XXX XXX
EV/Revenue 2.9x XXX 2.9x XXX XXX XXX
EV/EBITDA 19.1x XXX 20.1x XXX XXX XXX
EV/EBIT 25.8x XXX 28.4x XXX XXX XXX
EV/Gross Profit 3.9x XXX n/a XXX XXX XXX
P/E 34.8x XXX 38.6x XXX XXX XXX
EV/FCF 38.8x XXX 51.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Botanee Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Botanee Group Margins & Growth Rates

Botanee Group's last 12 month revenue growth is 8%

Botanee Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Botanee Group's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Botanee Group's rule of X is 36% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Botanee Group and other 15K+ public comps

Botanee Group Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 8% XXX 4% XXX XXX XXX
EBITDA Margin 15% XXX 14% XXX XXX XXX
EBITDA Growth 17% XXX -8% XXX XXX XXX
Rule of 40 27% XXX 23% XXX XXX XXX
Bessemer Rule of X XXX XXX 36% XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 40% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 5% XXX XXX XXX
Opex to Revenue XXX XXX 64% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Botanee Group Public Comps

See public comps and valuation multiples for Health & Beauty comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
SynBiotic XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Botanee Group M&A and Investment Activity

Botanee Group acquired  XXX companies to date.

Last acquisition by Botanee Group was  XXXXXXXX, XXXXX XXXXX XXXXXX . Botanee Group acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Botanee Group

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Botanee Group

When was Botanee Group founded? Botanee Group was founded in 2010.
Where is Botanee Group headquartered? Botanee Group is headquartered in China.
How many employees does Botanee Group have? As of today, Botanee Group has 4.0K+ employees.
Is Botanee Group publicy listed? Yes, Botanee Group is a public company listed on SHE.
What is the stock symbol of Botanee Group? Botanee Group trades under 300957 ticker.
When did Botanee Group go public? Botanee Group went public in 2021.
Who are competitors of Botanee Group? Similar companies to Botanee Group include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group.
What is the current market cap of Botanee Group? Botanee Group's current market cap is $2.7B
What is the current revenue of Botanee Group? Botanee Group's last 12 months revenue is $788M.
What is the current revenue growth of Botanee Group? Botanee Group revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Botanee Group? Current revenue multiple of Botanee Group is 2.9x.
Is Botanee Group profitable? Yes, Botanee Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Botanee Group? Botanee Group's last 12 months EBITDA is $120M.
What is Botanee Group's EBITDA margin? Botanee Group's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Botanee Group? Current EBITDA multiple of Botanee Group is 19.1x.
What is the current FCF of Botanee Group? Botanee Group's last 12 months FCF is $59.2M.
What is Botanee Group's FCF margin? Botanee Group's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Botanee Group? Current FCF multiple of Botanee Group is 38.8x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.